Literature DB >> 1563501

High prevalence of asthma in patients with bronchiectasis in Hong Kong.

M S Ip1, S Y So, W K Lam, L Yam, E Liong.   

Abstract

Eighty five Chinese patients with diffuse or localized bronchiectasis (non-cystic fibrosis) were studied regarding the prevalence of asthma. Twenty three of the 85 had concomitant asthma, diagnosed by history and reversibility on lung function testing either spontaneously or after bronchodilator. None fulfilled the diagnostic criteria of allergic bronchopulmonary aspergillosis (ABPA). Asthma preceded the onset of bronchiectasis in 13 patients and developed after long duration of bronchiectasis in seven, while the temporal onset could not be differentiated in three patients. Patients with both asthma and bronchiectasis had inferior spirometric values, higher prevalence of bronchial hyperresponsiveness to methacholine, higher prevalence of skin atopy, elevated serum immunoglobulin E (IgE), and more sputum eosinophilia, compared with their non-asthmatic counterparts. Possible mechanisms by which asthma and bronchiectasis predispose to each other include asthmatic obstruction contributing to development of bronchiectasis, and sensitization of airways with increased lability due to microbial colonization of the ectatic bronchial tree.

Entities:  

Mesh:

Year:  1992        PMID: 1563501

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  9 in total

1.  Impact of different etiologies of bronchiectasis on the pulmonary function tests.

Authors:  Agnaldo José Lopes; Gustavo Bittencourt Camilo; Sara Lucia Silveira de Menezes; Fernando Silva Guimarães
Journal:  Clin Med Res       Date:  2014-11-07

2.  Airflow obstruction in bronchiectasis: correlation between computed tomography features and pulmonary function tests.

Authors:  H R Roberts; A U Wells; D G Milne; M B Rubens; J Kolbe; P J Cole; D M Hansell
Journal:  Thorax       Date:  2000-03       Impact factor: 9.139

3.  Outcomes in children treated for persistent bacterial bronchitis.

Authors:  Deirdre Donnelly; Anita Critchlow; Mark L Everard
Journal:  Thorax       Date:  2006-11-14       Impact factor: 9.139

4.  The effects of bronchiectasis on asthma exacerbation.

Authors:  Hye Ran Kang; Gyu-Sik Choi; Sun Jin Park; Yoon Kyung Song; Jeong Min Kim; Junghoon Ha; Yung Hee Lee; Byoung Hoon Lee; Sang-Hoon Kim; Jae Hyung Lee
Journal:  Tuberc Respir Dis (Seoul)       Date:  2014-11-28

5.  The Saudi Thoracic Society guidelines for diagnosis and management of noncystic fibrosis bronchiectasis.

Authors:  Hamdan Al-Jahdali; Abdullah Alshimemeri; Abdullah Mobeireek; Amr S Albanna; Nehad N Al Shirawi; Siraj Wali; Khaled Alkattan; Abdulrahman A Alrajhi; Khalid Mobaireek; Hassan S Alorainy; Mohamed S Al-Hajjaj; Anne B Chang; Stefano Aliberti
Journal:  Ann Thorac Med       Date:  2017 Jul-Sep       Impact factor: 2.219

6.  Increased mortality in patients with non cystic fibrosis bronchiectasis with respiratory comorbidities.

Authors:  Hayoung Choi; Bumhee Yang; Jang Won Sohn; Hyun Lee; Yun Jin Kim; Sooim Sin; Yong Suk Jo; Youlim Kim; Hye Yun Park; Seung Won Ra; Yeon-Mok Oh; Sung Jun Chung; Yoomi Yeo; Dong Won Park; Tai Sun Park; Ji-Yong Moon; Sang-Heon Kim; Tae-Hyung Kim; Ho Joo Yoon
Journal:  Sci Rep       Date:  2021-03-29       Impact factor: 4.379

7.  A review of 151 cases of pediatric noncystic fibrosis bronchiectasis in a tertiary care center.

Authors:  Hanaa Hasan Banjar
Journal:  Ann Thorac Med       Date:  2007-01       Impact factor: 2.219

8.  Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study.

Authors:  Jennifer K Quint; Elizabeth R C Millett; Miland Joshi; Vidya Navaratnam; Sara L Thomas; John R Hurst; Liam Smeeth; Jeremy S Brown
Journal:  Eur Respir J       Date:  2015-11-05       Impact factor: 16.671

9.  Effect of radiological extent and severity of bronchiectasis on pulmonary function.

Authors:  Mehmet A Habesoglu; Fahri Tercan; Ugur Ozkan; Eyuboglu O Fusun
Journal:  Multidiscip Respir Med       Date:  2011-10-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.